Document:

evok-ex1034_394.htm

Exhibit 10.34

 

FOURTH AMENDMENT TO LEASE

 

 

            This Fourth Amendment to Lease (this “Amendment”) is made, for reference purposes only, February 3, 2022, by and between SB CORPORATE CENTRE III-IV, LLC, a Delaware limited liability company (“Landlord”), and EVOKE PHARMA, INC., a Delaware corporation (“Tenant”), with reference to the following facts:

 

 

RECITALS

 

A.               Landlord and Tenant are parties to that certain Office Lease Agreement dated as of December 19, 2016, as amended by that certain First Amendment to Lease dated as of September 27, 2018, as further amended by that certain Second Amendment to Lease dated as of December 6, 2019, as further amended by that certain Third Amendment to Lease dated as of December 15, 2020 (collectively, as amended, the “Lease”) for that certain premises located at 420 Stevens Avenue, Suite 370, Solana Beach, California 92075, consisting of approximately 3,031 Rentable Square Feet of commercial office space (the “Premises”).

 

B.               The parties desire to amend the Lease as set forth in this Amendment.

 

C.              All capitalized terms used in this Amendment, unless specifically defined herein, shall have the same meaning as the capitalized terms used in the Lease.

 

NOW, THEREFORE, for valuable consideration, the receipt and adequacy of which are expressly acknowledged, Landlord and Tenant agree as follows:

 

AGREEMENT

 

1.               Extension Term. The term of the Lease for the Premises is set to expire on January 31, 2022. By virtue of this Amendment, Landlord and Tenant hereby agree that the term of the Lease for the Premises shall be extended to and including the earlier to occur of (i) upon 30 days written notice from Landlord (in no event sooner than July 31, 2022) or (ii) October 31, 2022 (such actual date being the “Expiration Date”), subject to the terms and conditions contained herein and the Lease. For the purposes of this Amendment, the period of time between and including February 1, 2022 (the “Extended Term Effective Date”) and the Expiration Date shall be referred to herein as, the 

“Extension Term”. Furthermore, any and all previously granted and unexercised options to extend the term of the Lease shall be null and void and of no further force or effect.

 

2.               Rent. Tenant shall pay Basic Monthly Rent to Landlord for the Premises in advance on or before the first day of every calendar month, without any set-off or deduction, pursuant to the current rate as set forth in the Lease. However, as of the Extended Term Effective Date, Tenant’s Basic Monthly Rent for the Premises shall continue to be $12,427.10 during the Extension Term. 

 

3.               Tenant Certification. By execution of this Amendment, Tenant hereby certifies that as of the date hereof, neither Tenant nor Landlord is in default of the performance of its obligations pursuant to the Lease, and Tenant has no claim, defense, or offset with respect to the Lease.

 

4.               Real Estate Brokers. Tenant represents and warrants to Landlord that it has  not authorized or employed, or acted by implication to authorize or employ, with any real estate broker or sales person to act for it in connection with this Amendment or dealt with any real estate broker or sales person in connection with this Amendment other than RE:Align, Inc. Tenant also agrees to indemnify, defend and hold harmless Landlord from and against any and all claims by any real estate broker or salesman whom the Tenant authorized or employed, or acted by implication to authorize or employ, to act for Tenant in connection with this  Amendment, or with any broker or sales person with whom Tenant dealt in connection with this Amendment other than RE:Align, Inc.

 

5.               Confirmation. Except, as and to the extent modified by this Amendment, all provisions of the Lease shall remain in full force and effect. In the event of a conflict between the terms of the Lease and the terms of this Amendment, the terms in this Amendment shall control.

 

6.               Counterparts. This Amendment may be executed in any number of counterparts, including counterparts transmitted by facsimile or electronic mail, each of which shall be deemed an original for all purposes, and all counterparts shall constitute one and the same instrument.

 

7.               Electronic Signatures. Landlord and Tenant consent to the use of electronic signatures on this Amendment and all documents relating to the Lease and this Amendment, and any amendments to any of the foregoing (collectively, the “Lease Documents”). Landlord and Tenant agree that any electronic signatures appearing on the Lease Documents are the same as handwritten signatures for the purposes of validity, enforceability and admissibility, and that any electronically signed Lease Document shall, for all purposes of the Lease Documents and applicable law, be deemed to be “written” or “in writing”, to have been executed, and to constitute an original written record when printed, and shall be fully admissible in any legal proceeding. For purposes hereof, “electronic signature” shall have the meaning set forth in the Uniform Electronic Transactions Act, as the same may be amended from time to time.

 

 

 

IN WITNESS WHEREOF, Landlord and Tenant agree to the foregoing as evidenced by affixing their signatures below.

 

LANDLORD:                                                                      TENANT:

 

SB CORPORATE CENTRE III-IV, LLC                            EVOKE PHARMA, INC.

a Delaware limited liability company                                 a Delaware corporation

 

By:  American Assets Trust Management LLC

            a Delaware limited liability company, as

            Agent   

 

                                                                                          By:             /s/ David A. Gonyer

                                                                                          Name:       David A. Gonyer

                                                                                          Title:          President & CEO

                                                                                          Dated:       February 3, 2022

 

By:       /s/ Adam Wyll              

            President and COO

 

By:       /s/ Steven M. Center

            S.V.P. of Office Properties

 

Dated: February 3, 2022ex_344637.htm

Exhibit 10.1

 

AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED

CONVERTIBLE PROMISSORY NOTE 

 

THIS AMENDMENT NO.1 TO SECOND AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE, dated as of March 4, 2022 (this “Amendment”), amends the Second Amended and Restated Convertible Promissory Note initially issued on April 16, 2018 (as heretofore amended, the “Note”) by ThermoGenesis Holdings, Inc., a Delaware corporation formerly known as Cesca Therapeutics Inc. (the “Company”), to Boyalife Asset Holding II, Inc., an Illinois corporation (the “Holder”) pursuant to that certain First Amended and Restated Revolving Credit Agreement between the Holder and the Company, as amended.

 

WHEREAS:

 

	
			A.

				
			The Company and the Holder desire to hereby amend the Note in the manner set forth below.

			

 

NOW, THEREFORE, for and in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holders hereto agree as follows:

 

	
			1.

				
			The “Maturity Date” set forth in paragraph three of the Note is hereby amended to be “March 6, 2023.”

			

 

	
			2.

				
			Paragraph two of the Note shall be deleted in its entirety and replaced with the following:

			

 

“2.         Interest. This Note shall bear simple interest (calculated on the basis of a 360-day year for the actual number of days elapsed) at the annual rate of twenty-two percent (22.0%) of the principal amount of this Note outstanding from time to time, and if such rate is determined to be usurious, then the rate shall be reduced to the highest legally permissible rate. Accrued and unpaid interest as of March 6, 2022 shall become due and payable on March 6, 2022. After March 6, 2022, accrued and unpaid interest shall become due and payable annually on December 31st of each year.”

 

	
			3.

				
			An executed copy of this Amendment shall be affixed or be deemed affixed to the Note. Except as specifically set forth in this Amendment, all of the terms and provisions of the Note, as heretofore amended, shall continue to remain in full force and effect. This Amendment is not intended to be, and shall not constitute, a substitution or novation of the Note.

			

 

	
			4.

				
			Capitalized terms appearing in this Amendment and not otherwise defined herein shall have the meanings ascribed thereto in the Note.

			

 

	
			5.

				
			This Amendment may be executed in any number of counterparts with the same effect as if all parties hereto had signed the same document. This Amendment, together with the Note (as heretofore amended), contains the final, complete, and exclusive expression of the parties’ understanding and agreement concerning the matters contemplated herein and supersedes any prior or contemporaneous agreement, oral or written, among them.

			

 

	
			6.

				
			Each and every term and provision of this Amendment shall be binding upon and shall inure to the benefit of the Holder and its successors and assigns.

			

 

	
			7.

				
			This Amendment shall be governed by and construed under the laws of the State of California, without giving effect to the principles of conflicts of law thereof. Any claims or legal actions arising hereunder shall be commenced and maintained in any state or federal court of competent jurisdiction located in the State of California, and the Holder consents and submits to the exclusive jurisdiction and venue of any such court.

			

 

[signature page follows]

 

-2-

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment to Second Amended and Restated Convertible Promissory Note as of the first date set forth above.

 

 

	
			 

				
			COMPANY: 

				
			 

			
	 	 	 
	 	THERMOGENESIS HOLDINGS, INC.	 
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			By: 

				
			/s/ Jeffery Cauble

				
			 

			

 

[Signature Page to Amendment to Second Amended and Restated Convertible Promissory Note]

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment to Second Amended and Restated Convertible Promissory Note as of the first date set forth above.

 

	
			 

				
			HOLDER: 

				
			 

			
	 	 	 
	 	BOYALIFE ASSET HOLDING II, INC.	 
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			 

				
			/s/ Xiaochun Xu

				
			 

			

 

 

[Signature Page to Amendment to Second Amended and Restated Convertible Promissory Note]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]